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Abstract
Background: Chronic diseases and multimorbidity are increasingly common among persons in working age. This
study explores the impact of type, number and combinations of chronic diseases with focus on the role of MSKD
on (1) adverse work status (i.e. work disability (WD), economic unemployment (UE) or receiving a living allowance
(LA)) and on (2) the occurrence of sick leave.
Methods: Subjects participating in a Dutch household survey, who were ≤65 years and could have paid work,
provided data on socio-demographics and nine physician diagnosed chronic diseases. To explore the independent
association of each chronic disease, of multimorbidity and of MSKD in context of multimorbidity with 1) work status
(employed, WD, LA, UE) and 2) sick leave (SL) in those employed, multinomial logistic regressions and logistic
regressions were used, respectively.
Results: Among 5396 subjects, MSKD was the most common morbidity (17%), multimorbidity occurred in 755/5396
(14%), 436/755 (61%) of subjects with multimorbidity had an MSKD. For MSKD the odds of WD, LA and UE were 2.06
[95% CI 1.56;2.71], 2.15[1.18;3.91] and 1.35[0.94;1.96], respectively, compared to being employed and the odds of SL in
MSKD were 2.29[1.92;2.73]. Mental diseases had a stronger impact on all these outcomes. The odds for adverse work
outcomes increased strongly with an increasing number of diseases. When an MSKD was part of multimorbidity, an
additional impact on the association with WD and SL was observed.
Conclusions: Multimorbidity has a stronger impact on all work outcomes compared to single chronic diseases. The
presence of the MSKD in the context of multimorbidity amplifies the chance of WD or SL.
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Background
Worldwide, chronic diseases are becoming increasingly
prevalent, partly as a consequence of ageing and earlier
diagnosis, but also as a consequence of lifestyle changes.
According to the Global Burden of Disease initiative,
musculoskeletal (MSKD), cardiovascular (CVD),
respiratory, mental and gastro-intestinal diseases, dia-
betes and, somewhat less frequent, cancer are among
the most common chronic diseases [1]. In the
Netherlands, approximately 31% of the general popula-
tion reports at least one chronic condition [2]. As the in-
cidence and prevalence of all these conditions is age
dependent, the rise is particularly impressive in persons
after the age of 50 years. Parallel with this rise, the oc-
currence of multimorbidity, i.e. the co-occurrence of two
or more diseases in one person, is more frequently ob-
served [3, 4].
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Existing literature on chronic diseases and multimor-
bidity mainly focused on the prevalence and the impact
on health related quality of life. However, since diagno-
ses of chronic diseases are increasingly made at younger
age, and as in many Western countries the age of retire-
ment is systematically raised to deal with the financial
burden associated with the aging of the population,
chronic conditions and multimorbidity have potentially
large effects on labor force participation [5–8].
Among chronic diseases, MKSD, together with mental
diseases, are the main reason of expenditures for work dis-
ability (WD) and sick leave (SL) in Western countries when
accounting for their prevalence [9, 10]. Nonetheless, com-
parisons of the relative impact of major chronic diseases on
work outcomes have rarely been performed [11, 12]. Yet,
such knowledge could be of interest, as similar adverse im-
pact of all chronic diseases on work participation could call
for a shared responsibility across medical specialties. Also,
the majority of studies concentrate on work disability and/
or sick leave as adverse work outcome. However, to obtain
a broad view on the consequences of chronic diseases on
work participation, it is important to study the impact on
sick leave in those still working but also the impact on work
disability, (economic) unemployment (UE) and dependence
on living allowances (LA). With respect to the latter two
outcomes it should be recognized that not all persons with
a chronic condition are eligible for an official work disability
allowance, but will be vulnerable on the labor market and
therefore become (or remain) unemployed and finally
dependent on a living allowance.
Existing literature on the impact of multimorbidity on
work outcomes is scarce and often restricted to the study
of two specific combinations of diseases such as rheuma-
toid arthritis (RA) and depression or cardiovascular dis-
ease [13, 14], and as such addresses the influence of
comorbidities on the disease of interest (in this example
RA). The lack of interest in multimorbidity is surprising,
given that multimorbidity might well be a strong and rele-
vant risk factor for adverse work outcome. Several ques-
tions can be raised. First, how strong is the impact of
increasing numbers of comorbidities on the different work
outcomes. Second, what counts most, the number of mor-
bidities or to specific combinations chronic diseases. Espe-
cially from the rheumatologist’s point of view, it would be
interesting to understand whether the presence of an
MSKD as part of multimorbidity would amplify the impact
of multimorbidity on adverse work outcome. An amplify-
ing role of MSKD would argue for special attention for pa-
tients that have an MSKD as part of their multimorbidity.
The current study aimed to compare the impact of type,
number and combinations of chronic diseases with focus
on the role of MSKD on (1) adverse work status (i.e. work
disability, economic unemployment or receiving a living
allowance) and on (2) the occurrence of sick leave.
We hypothesized that all chronic diseases are associ-
ated with an increased risk of work disability compared
to the general population and to a lesser extent with un-
employment and dependence on a living allowance and
that the presence of a MSKD in multimorbidity patterns
is associated with a higher risk of adverse work outcome
than multimorbidity patterns without MSKD.
Methods
Data from The National Monitor on Musculoskeletal Sys-
tem 2010, a household survey conducted by the Dutch
organization for applied scientific research were used [15].
The study was approved by the Medical Ethical Committee
of the Leiden University Medical Center. The detailed
approach of sampling and data collection is described else-
where [16]. In brief, a random sample of Dutch households
was contacted by letter and members of the household
older than 18 years who were the next to have their birth-
day were invited to complete and return the questionnaire.
Among others, information was collected on socio-
demographics (age, gender, highest level of achieved educa-
tion (i.e. no or primary education, lower professional,
middle or secondary professional, general secondary (high
school) or higher professional or university education),
origin (western, first generation non-western, second
generation non-western), lifestyle (weight and height,
computed into BMI (kg/m2; underweight <18.5; normal:
18.5- < 25.0; pre-obese: 25.0- < 30.0; obese: ≥30.0));
smoking-status (never, past, current)), nine self-reported
physician-diagnosed diseases over the last year (i.e. MSKD
(defined as severe, persisting complaints in or around
joints), diabetes, cardiovascular disease (CVD, defined as
hypertension, cerebral hemorrhage/stroke, myocardial in-
farction, other heart-diseases or peripheral vascular dis-
ease), cancer, migraine, respiratory disease, skin disease,
mental diseases and gastrointestinal disease), work status
(being employed, being retired, being economically un-
employed, WD, receiving LA, being housewife or house-
man, being a student) and having been on sick leave (SL
(yes/no)) during the past 12 months when employed. In
this study, we considered ≥ 2 chronic diseases in one per-
son as multimorbidity [3, 4]. The presence of one of the
nine chronic diseases, regardless of the presence of other
diseases, was referred to as the ‘index disease’ and the pres-
ence of one of the nine diseases only (no other disease
present) was referred to as ‘single disease’.
Statistical analyses
Persons of working age (18–65 years) who had paid
work, were WD, UE or depending on a LA were in-
cluded in the analyses when work status was the out-
come. When SL in the last 12 months was the outcome,
the sample was restricted to those with paid work who
answered the question on sick leave.
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Work disability, economic unemployment and receiving a
living allowance
To assess the odds to be WD, UE or depending on a LA
for subjects with the different morbidities or morbidity
patterns compared to having paid work, multinomial re-
gressions were used. Multinomial regressions are useful
when the outcome (having no work) can be further clas-
sified in different categories (work disabled, economic-
ally unemployed or receiving a living allowance).
First, a multinomial regression was performed with the
different chronic diseases (index disease compared to no
index disease) as the independent variables of interest.
Next, a multinomial regression was performed with the
number of morbidities (1; 2; 3; ≥4 diseases, reference = no
disease reported) as independent variable of interest.
Thirdly, a multinomial regression was computed with sin-
gle diseases (i.e. presence of only one disease) and multi-
morbidity including MSKD and multimorbidity excluding
MSKD as independent variables of interest (reference = no
disease). In a scenario analysis, this model was repeated
when those with multimorbidity were further classified
into 2 or ≥3 diseases with or without MSKD. From the re-
sults of the model with the number of morbidities, the
predicted probability of work disability with increasing
morbidities and age was calculated for a non-smoking
subject with middle or professional secondary education
and normal BMI, averaged for gender.
Sick leave
To explore the association of the different chronic dis-
eases (index disease), the number of diseases, or single dis-
eases and multimorbidity in- and excluding MSKD with
sick leave logistic regressions were computed. In a sce-
nario analysis, the model including single diseases and
multimorbidity was repeated when those with multimor-
bidity were further classified into 2 or ≥3 diseases with or
without MSKD.
Model development
In all models, age, gender, BMI, smoking status, origin
and education were considered potential confounders.
Manual forward selection was used to develop fully ad-
justed models. Variables remained in the multivariable
model when they were either significantly associated with
the outcome (p ≤ 0.05) or confounded the association of
the disease (dependent) with the outcome (i.e. ≥10%
change in the coefficient). All analyses were performed on
complete cases using STATA statistical software 12.0 [17].
Results
The questionnaire was returned by 8904 (22.4%) sub-
jects of whom 5396 were ≤65 years and were either
employed (n = 4805; 89%), WD (n = 350; 7%), depend-
ing on LA (n = 57; 3%) or UE (n = 184; 3%).
The mean age was 46 years (SD 11) and 3008 (56%)
were women (Table 1). MSKD was reported by 925 sub-
jects (17%), 662 (12%) had CVD, 180 (3%) diabetes, 96
(2%) cancer, 355 (7%) respiratory disease, 359 (7%) skin
disease, 376 (7%) mental disease, 164 (3%) a bowel (i.e.
gastro-intestinal) disease and 275 (5%) migraine. Multi-
morbidity was present in 14% (n = 755) of the cases. Of
all persons with 2 morbidities 265/490 (54%) reported
an MSKD and of all persons with ≥3 morbidities 198/
265 (75%) reported an MSKD (Table 2).
In the total group, the disease that was most preva-
lent among persons with adverse work outcome was
MSKD: 43% (152/350) of those with a WD, 42% (24/
57) of those with a LA and 23% (43/184) of those
with UE had an MSKD.
Table 1 Characteristics of the study population* (N = 5396)
Age, mean (SD) 45.8 (11.0)
Women, n (%) 3008 (55.8)
Work status
Paid work 4,805 (89.1)
Work disabled 350 (6.5)
Unemployed 184 (3.4)






Level of education, n (%) n = 5357
Primary school or no education 105 (2.0)
Lower professional school 544 (10.2)
Middle or professional secondary school 1677 (31.3)
Secondary education 567 (10.6)
University education 2464 (46.0)
Smoking status, n (%) n = 5381
Current smoker 1057 (19.6)
Never smoked 2535 (47.1)
Former smoker 1789 (23.3)




≥ 3 265 (4.9)
Sick leave during past 12 months in
subsample with paid work
n = 4805
Yes, sick leave n (%) 2264 (47.1)
aPopulation is ≤ 65 years, has either paid work, is work disabled, unemployed
or is depending on a living allowance)
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An overview of the characteristics of the subsample with
paid work (n = 4805), in which the occurrence of sick
leave in the past year was studied, is presented in
Additional file 1. MSKD was reported by 706 (15%), multi-
morbidity was present in 493 (10%) subjects and of those
with multimorbidity 286 (58%) reported an MSKD.
Work disability, economic unemployment or receiving a
living allowance compared to paid work
The model addressing the impact of the different
chronic disease on work status showed that patients
with MSKD had significantly higher odds to be WD (OR
2.06 [95% CI 1.56; 2.71]) and have a LA (2.15 [1.18;
3.91]) but not to be UE (1.35 [0.94; 1.96]) when using
“paid work” as the reference outcome. Similar patterns
were observed for other diseases. However, the strongest
association with all work outcomes was seen for mental
diseases (Table 3).
In the model addressing the association of an increasing
number of morbidities with work status, the odds of WD
in persons with one morbidity were OR 3.31 [2.35; 4.65].
Each additional morbidity was associated with a steep in-
crease in odds of WD (Table 4). Figure 1 illustrates the
predicted probability of WD with an increasing number of





































Age, mean (SD) 49.0 (10.5) 53.3 (8.8) 54.8 (8.0) 54.0 (8.5) 48.3 (11.0) 46.7 (11.0) 46.0 (11.0) 46.6 (11.1) 45.2 (10.9) 44.0 (10.8)
Women, n (%) 563 (60.9) 333 (50.3) 72 (40.0) 63.0 (65.6) 227 (63.9) 208 (57.9) 253 (58.0) 124 (75.6) 231 (84.0) 1685 (53.4)
Work status
Paid work 706 (76.3) 509 (76.9) 115 (63.9) 64 (66.7) 265 (74.7) 281 (78.3) 216 (57.5) 108 (65.9) 203 (73.8) 2998 (95.0)
Work disabled 152 (16.4) 113 (17.1) 46 (25.6) 26 (27.1) 66 (18.6) 56 (15.6) 121 (32.2) 46 (28.1) 45 (16.4) 86 (2.7)
Unemployed 43 (4.7) 25 (3.8) 11 (6.1) 5 (5.2) 13 (3.7) 17 (4.7) 25 (6.7) 6 (3.7) 23 (8.4) 56 (1.8)
Living allowance 24 (2.6) 15 (2.3) 8 (4.4) 1 (1.0) 11 (3.1) 5 (1.4) 14 (3.7) 4 (2.4) 4 (1.5) 16 (0.5)
BMI, n (%) n = 269
Underweight 15 (1.6) 2 (0.3) 1 (0.6) - 4 (1.1) 6 (1.7) 11 (2.9) 4 (2.4) 7 (2.6) 42 (1.3)
Normal 387 (41.8) 200 (30.2) 34 (18.9) 37 (38.5) 143 (40.3) 173 (48.2) 179 (47.6) 79 (48.2) 145 (52.7) 1858 (58.9)
Pre-obese 340 (36.8) 261 (39.4) 66 (36.7) 39 (40.6) 121 (34.1) 122 (34.0) 108 (28.7) 57 (34.8) 76 (27.6) 980 (31.1)
Obese 183 (19.8) 199 (30.1) 79 (43.9) 20 (20.8) 87 (24.5) 58 (16.2) 78 (20.8) 24 (14.6) 47 (17.5) 225 (7.1)
Level of education, n (%) n = 922 n = 656 n = 179 n = 352 n = 358 n = 374 n = 274 n = 3133
Primary school or no
education
29 (3.2) 25 (3.8) 11 (6.2) 4 (4.2) 13 (3.7) 12 (3.4) 9 (2.4) 7 (4.3) 3 (1.1) 43 (1.3)
Lower professional
school
154 (16.7) 102 (15.6) 37 (20.7) 15 (15.6) 59 (16.8) 48 (13.4) 45 (12.0) 22 (13.4) 38 (13.9) 244 (7.8)
Middle or professional
secondary school
331 (35.9) 245 (37.4) 57 (31.8) 28 (29.2) 121 (34.4) 118 (33.0) 126 (33.7) 56 (34.2) 94 (34.2) 920 (29.4)
Secondary education 90 (9.7) 75 (11.4) 20 (11.2) 21 (21.9) 32 (10.5) 40 (11.2) 52 (13.9) 18 (11.0) 34 (12.4) 311 (9.9)
University education 318 (34.5) 209 (31.9) 54 (30.2) 28 (29.2) 127 (36.1) 140 (39.1) 142 (38.0) 61 (37.2) 105 (38.3) 1615 (51.5)
Smoking status, n (%) n = 924 n = 660 n = 179 n = 353 n = 163 n = 3145
Current smoker 217 (23.5) 131 (19.9) 42 (23.5) 20 (20.8) 73 (20.7) 74 (20.6) 118 (31.4) 41 (25.2) 64 (23.3) 567 (18.0)
Never smoked 364 (39.4) 248 (37.6) 50 (27.9) 35 (36.5) 155 (43.9) 141 (39.3) 122 (32.5) 77 (47.2) 128 (46.6) 1610 (51.2)
Former smoker 343 (37.1) 281 (42.6) 87 (48.6) 41 (42.7) 125 (35.4) 144 (40.1) 136 (36.2) 45 (27.6) 83 (30.1) 968 (30.8)
Number of co- morbidities, n (%)
0 462 (50.0) 289 (43.7) 46 (25.6) 39 (40.6) 143 (40.3) 175 (48.8) 162 (43.1) 65 (39.6) 123 (44.7) 3156
(100.0)
1 265 (28.7) 197 (29.8) 62 (34.4) 23 (24.0) 103 (29.0) 101 (28.1) 107 (28.5) 49 (29.9) 79 (28.7) N/A
2 132 (14.3) 106 (16.0) 40 (22.2) 21 (21.9) 61 (17.2) 58 (16.2) 67 (17.8) 24 (14.6) 50 (18.2) N/A
≥ 3 66 (7.1) 70 (10.6) 32 (17.8) 13 (13.5) 48 (13.5) 25 (6.9) 40 (10.6) 26 (15.9) 23 (8.4) N/A
Sick leave during past 12 months in subsample with paid work
n = 706 n = 509 n = 115 n = 64 n = 265 n = 281 n = 216 n = 108 n = 203 n = 2992
Yes, sick leave n (%) 455 (64.5) 257 (50.5) 66 (57.4) 40 (62.5) 154 (58.1) 154 (54.8) 164 (75.9) 69 (63.9) 136 (67.0) 1173 (39.2)
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morbidities and with increasing age. The odds of depend-
ing on LA or being UE became significantly increased
when more than one morbidity was present
The model addressing the association of single diseases
or multimorbidity with or without MSKD with work status
revealed that when an MSKD was part of multimorbidity,
the odds of WD, dependence on LA and UE increased (al-
though not significantly) (Table 4). When exploring the in-
fluence of the presence of an MSKD in the context of 2 or
≥3 morbidities similar trends (adverse influence of presence
of an MSKD) were seen (Additional file 2). Additional ana-
lyses on the impact of specific combinations of MSKD with
each of the other chronic disease revealed that the co-
occurrence of MSKD, cancer and mental diseases had the
largest impact on WD and that co-occurrence of MSKD
and mental diseases had the strongest association with
dependence on LA and UE (Additional file 3).
Sick leave
Among those employed, persons with MSKD had increased
odds for sick leave (2.29 [1.92; 2.73]). Persons with mental
diseases (3.24 [2.33;4.52]) or cancer (2.20 [1.28;3.76]) had
higher or comparable odds, respectively (Table 5).
While the odds of sick leave were significantly higher in
persons having (any) single morbidity compared to those
without a disease (OR 2.00 [95% CI 1.75; 2.30]), the odds of
sick leave increased with increasing number of morbidities
(Table 5). The odds of sick leave were significantly higher
Table 3 Adjusted association between the presence of a chronic disease (index disease) and work disability, dependence on living
allowances, and economic unemployment compared to ‘being employed’






Musculoskeletal disease 2.06 [1.56; 2.71] 2.15 [1.18; 3.91] 1.35 [0.94; 1.96]
Cardiovascular disease 1.61 [1.18; 2.21] 1.29 [0.64; 2.62] 0.88 [0.55; 1.40]
Diabetes 2.32 [1.47; 3.67] 3.40 [1.38; 8.37] 1.88 [0.95; 3.72]
Cancer 3.26 [1.82; 5.85] 0.69 [0.09; 5.49] 1.73 [0.67; 4.48]
Respiratory disease 1.72 [1.16; 2.55] 2.02 [0.94; 4.38] 1.08 [0.59; 1.94]
Skin disease 1.96 [1.34; 2.86] 1.02 [0.38; 2.75] 1.37 [0.81; 2.32]
Mental disease 10.54 [7.69; 14.44] 5.60 [2.77; 11.34] 3.03 [1.91; 4.80]
Bowel disease 2.89 [1.74; 4.79] 1.65 [0.52; 5.29] 1.10 [0.46; 2.60]
Migraine 2.03 [1.30; 3.18] 1.13 [0.38; 3.40] 3.10 [1.90; 5.04]
Results of multivariable multinomial regression model adjusted for age, gender, education, BMI, smoking status (n = 5340)
Abbreviations: OR odds ratio, CI confidence interval
aPaid work is the reference outcome
bAbsence of index disease is the reference category
Table 4 Adjusted association between the number of diseases and multimorbidity, in- and excluding musculoskeletal disease, and
work status compared to ‘being employed’






1 3.31 [2.35;4.65]a 1.46 [0.69; 3.10] 1.32 [0.92;1.88]
2 9.16 [6.32;13.27]a 3.76 [1.67; 8.46]a 2.55 [1.63;4.00]a
3 14.03 [8.88; 22.16] 6.37 [2.46; 16.51] 3.08 [1.60;5.92]
≥ 4 30.33 [14.87; 61.85]a 16.29 [4.94; 53.67] 4.50 [1.58;13.62]
Single and multimorbidity in- and excluding MSKDϮ
Single morbidity being an MSKD 2.00 [1.19; 3.39]b 1.39 [0.49; 3.99] 1.23 [0.71; 2.14]
Single morbidity other than MSKD 3.91 [2.73; 5.60] 1.48 [0.64; 3.47] 1.36 [0.91; 2.02]
Multimorbidity including MSKD 14.35 [10.02; 20.56] 6.32 [2.99; 13.35] 2.84 [1.78; 4.53]
Multimorbidity excluding MSKD 9.92 [6.54; 15.05] 3.34 [1.25; 8.94] 2.65 [1.54; 4.58]
Results of multivariable multinomial regression model adjusted for age, gender, education, BMI & smoking-status (n = 5340)
Abbreviations: MSKD musculoskeletal disorder, OR odds ratio, CI confidence interval
*Paid work is the reference outcome
ϮNo morbidity is the reference category
aSignificantly different from estimate for previous disease count (i.e.1 vs. 0; 2 vs. 1 etcetera)
bSignificantly different from estimate for single morbidity other than MSKD
cSignificantly different from estimate for multimorbidity excluding MSKD
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when a MSKD was part of the multimorbidity (OR 1.70
[95% CI 1.15;2.51]) (Table 5). An amplifying effect of the
presence of an MSKD on SL was seen irrespective of the
number of morbidities present (Additional file 4).
Discussion
Although we hypothesized that MSKD would have stronger
associations with work outcomes when compared to other
conditions, data revealed that all chronic diseases were as-
sociated with WD and depending on LA. On the same line,
the majority of conditions were also associated with the
likelihood of incurring SL in the previous 12 months. As
expected, when the number of morbidities increases, the
odds of any adverse work outcome increased as well. Con-
sistent with our hypothesis, the presence of MSKD in the
context of multimorbidity tended to amplify the risk for ad-
verse work outcome and especially of sick leave.
While from a societal point of view MSKD and mental
diseases account for the majority of expenditures for SL
and WD in most of Western countries, our data emphasize
that for MSKD this is mainly attributable to their higher
prevalence among persons in the working age range. When
comparing the relative impact on adverse work outcomes
across diseases, mental diseases clearly have the largest im-
pact on WD and LA, but for all other chronic diseases the
association with WD and depending on a LA was in the
same range. An exception was the association with sick
leave, where no impact for CVD, diabetes and skin diseases
was observed, but where patients with mental disease
followed by MSKD and cancer incurred substantial SL in
the previous 12 months.
Only few studies compared the relative impact of dis-
tinct chronic diseases on the different types of work out-
comes. In an international study across 10 European
countries including 11,462 patients, Alavinia et al. com-
pared the association of heart attack, hypertension,
stroke, diabetes, chronic lung disease and asthma and
depressive symptoms with economic unemployment,
after excluding persons with official work disability [12].
They found that the chronic diseases studied had no im-
pact on economic UE, except for the presence of depres-
sive symptoms. On the other hand, a prospective study
among 707 Finnish construction workers showed that
health problems predict long term unemployment. In
this study unemployment was defined as joblessness lon-
ger than 24 months and it is unclear to what extent this
was related to economic unemployment or official work
disability [18]. However, our data suggest that not all
persons with a chronic condition are eligible for an offi-
cial work disability allowance, but apparently they are
still vulnerable on the labor market and therefore be-
come (or remain) unemployed and finally become






20 30 40 50 60
age
1 disease 2 diseases
3 diseases 4 diseases
Fig. 1 Predicted probability* of work disability by number of
morbidities at indicated age.
*Predicted probability for non-smoking subjects with middle or
professional secondary education and normal BMI based on model
estimates shown in Table 3




Musculoskeletal disease 2.29 [1.92; 2.73]
Cardiovascular disease 1.21 [0.99; 1.49]
Diabetes 1.46 [0.97; 2.20]
Respiratory disease 1.37 [1.05; 1.79]
Mental disease 3.24 [2.33; 4.52]
Cancer 2.20 [1.28; 3.76]
Skin disease 1.24 [0.96; 1.61]
Bowel disease 1.54 [1.01; 2.34]
Migraine 1.91 [1.39; 2.63]
Number of morbidities*
1 2.00 [1.75; 2.30]a
2 2.72 [2.14; 3.44]a
3 4.22 [2.74; 6.51]
≥ 4 8.19 [2.73; 24.59]
Single morbidity/multimorbidity in- and excluding MSKD*
Musculoskeletal disease 2.50 [2.01; 3.10]b
Any disease excl. MSKD 1.81 [1.55; 2.12]
Multimorbidity including MSKD 4.04 [3.07; 5.34]c
Multimorbidity excluding MSKD 2.40 [1.78; 3.24]
Results of multivariable logistic regression models adjusted for age, gender,
level of education, origin, BMI and smoking status (n = 4770)
Abbreviations: MSKD musculoskeletal disorder, OR odds ratio, CI
confidence interval
+reference category = population without the index disease
*reference category = healthy population
aSignificantly different from estimate for previous disease count (i.e.1 vs. 0; 2
vs. 1 etcetera)
bSignificantly different from estimate for single morbidity other than MSKD
cSignificantly different from estimate for multimorbidity excluding MSKD
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The large impact of MSKD on increased sick leave, es-
pecially in those with mental disease and MSKD, has been
previously identified [19, 20], but our study showed that
mental diseases and cancer had an equally large or even
larger impact. On the same line, Kessler et al. showed (al-
though not distinguishing between paid and unpaid work)
that when comparing the impact of chronic diseases (i.e.
arthritis, asthma, diabetes, high blood pressure, auto-
immune disease, ulcers, heart disease and several mental
diseases) on the number of days that work had to be cut
back or in which participants were unable to work, mental
diseases had the strongest impact on reduced work-days
followed by ulcers and arthritis [11]. Although our study
concentrated on sickness absence in those with paid work,
it is not surprising that the same diseases also provided
problems in being productive in unpaid work.
Multimorbidity had a consistent and strong impact on all
aspects of work outcome, also consistently on sick leave
and economic UE. This suggests that the combination of
individual chronic diseases is additionally hindering work
opportunities, which is supported by the steep increase in
odds of unfavorable work outcome with increasing number
of diseases. Of interest, in the context of multimorbidity,
the presence of an MSKD tended to amplify the adverse
impact on work outcome, although only statistically signifi-
cant when sick leave was the outcome. Unfortunately, our
sample was not large enough to retrieve stable estimates for
the association of all combinations of two diseases. Within
this limitation, analysis revealed that the combination of
MSKD and mental diseases as well as also cancer and
MSKD had indeed the largest impact on adverse work out-
come. The detrimental combination of depression and RA
on WD has been shown previously [14, 21]. However, to
our knowledge no further literature exists regarding the im-
pact of multimorbidity in- and excluding an MSKD on ad-
verse work outcome.
Some limitations deserve attention. The overall response
rate of 22.4% was low but comparison of socio-
demographic characteristics with data of the central office
for statistics in the Netherlands only showed minor differ-
ences (Additional file 5), which suggests our results are
fairly generalizable. Further, data on chronic diseases and
the outcomes were self-reported which might result in mis-
classification of exposure and outcome. However, studies
suggest that self-reported diagnoses that specify that the
disease should be confirmed by a physician (which was the
case in this study) reduce the bias [22, 23]. While more spe-
cific data on diagnoses included in MSKD was available
and analyses in subgroups would have been favorable, we
were not able to analyze the specific diagnoses in MSKD
group due to small numbers of subjects of working age in
each diagnosis group. As in all cross-sectional studies, our
findings can only be interpreted in terms of associations
and no conclusions on causality can be drawn.
Furthermore, our sample concerns the Dutch population
only and therefore may have limited generalizability to
other countries. Existing difference in criteria to receive a
work disability pensions, or a LA, and in prevailing UE
rates, will obviously impact the likelihood of being eligible
for a WD or the likelihood to become long-term UE or
dependent on a LA. Last but not least, we have no data on
specific diagnoses within the larger disease groups, nor on
objective severity and duration of disease, hampering
detailed information on disease characteristics related to
adverse work outcome.
The strength of this study is the variety of work outcomes
included and the novel insights it gives into the impact of
(multi)morbidity on these outcomes. Our results call for
common action for all those involved in care for patients
with chronic diseases to address work ability and assess risk
for adverse work outcome in all chronic diseases and espe-
cially in those with multimorbidity. First and foremost, pre-
vention of adverse work outcome is mandatory and a duty
for all professionals involved in the care of persons with
chronic diseases. It is known that sick leave is a strong pre-
dictor of WD, and especial persons who are already on sick
leave should receive additional support from the medical
team to remain in labor force. Rheumatologists may play a
role in the identification of patients at risk for adverse work
outcome and support them in gaining self-management
skills that help in maintaining their work. Further, in cur-
rently economically unfavorable times, efforts should be
made by policy makers and employers to prevent that per-
sons with (multiple) chronic disease will lose their job and/
or to help them return to (other) work.
Conclusion
In conclusion, chronic diseases (the presence of any of
them) and specifically multimorbidity have an important
association with the broad spectrum of adverse work out-
comes. Our findings emphasize the need to develop com-
mon strategies among all chronic disease to improve work
outcome in daily clinical care. Professionals in rheumato-
logical care could take the lead for such initiatives.
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